Odyssean »

Brighthouse Finl shares owned by Odyssean

Quarter-by-quarter ownership of Brighthouse Finl (BHF) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Brighthouse Finl

Tip: Access up to 7 years of quarterly data

All positions including Brighthouse Finl held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brighthouse Finl by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $338k 5.3k 63.30

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Brighthouse Finl

BlackRock
UBS Group
Dimensional Fund Advisors
DME Capital Management
American Century Companies
Vanguard Capital Management
Vanguard Portfolio Management
Glazer Capital
State Street Corporation
Morgan Stanley
Millennium Management
Soros Fund Management
Geode Capital Management
Alliancebernstein
Susquehanna International

View all funds holding Brighthouse Finl